Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02441309
What this trial is testing

A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)

Who this might be right for
Osteosarcoma
University of Oxford 8
Large-scale testing (Phase 3)Study completedNCT00049452
What this trial is testing

Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Herbert Irving Comprehensive Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT00903760
What this trial is testing

Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndrome
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Ended earlyNCT05086315
What this trial is testing

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more
Sanofi 101
Large-scale testing (Phase 3)Study completedNCT00471497
What this trial is testing

Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia, Chronic
Novartis Pharmaceuticals 846
Not applicableStudy completedNCT02132182
What this trial is testing

Monocyte Phenotypic and Functional Differences

Who this might be right for
Osteosarcoma
Duke University 15
Testing effectiveness (Phase 2)Ended earlyNCT02877082
What this trial is testing

Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients

Who this might be right for
Acute LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+9 more
Emory University 5
Testing effectiveness (Phase 2)Study completedNCT02296242
What this trial is testing

Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
BioMed Valley Discoveries, Inc 53
Testing effectiveness (Phase 2)Study completedNCT00014573
What this trial is testing

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT04849910
What this trial is testing

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Vor Biopharma 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT02917720
What this trial is testing

2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

Who this might be right for
Chronic Myeloid Leukemia
European LeukemiaNet 75
Testing effectiveness (Phase 2)Study completedNCT00702403
What this trial is testing

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT01802450
What this trial is testing

Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia
PETHEMA Foundation 18
Testing effectiveness (Phase 2)Study completedNCT02470091
What this trial is testing

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Who this might be right for
Metastatic OsteosarcomaRecurrent OsteosarcomaRefractory Osteosarcoma+3 more
Children's Oncology Group 56
Testing effectiveness (Phase 2)Looking for participantsNCT07025824
What this trial is testing

Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

Who this might be right for
AML - Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)
Technische Universität Dresden 220
Not applicableLooking for participantsNCT02677961
What this trial is testing

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Who this might be right for
Neoplasms, Connective and Soft TissueBone Neoplasms
Ohio State University Comprehensive Cancer Center 1,500
Not applicableStudy completedNCT00001686
What this trial is testing

Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases

Who this might be right for
Ewing's SarcomaLeukemiaLymphoma+2 more
National Cancer Institute (NCI) 482
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00769327
What this trial is testing

Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 129
Early research (Phase 1)Study completedNCT00098423
What this trial is testing

Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+23 more
National Cancer Institute (NCI) 42
Next Page